Monday, 4 June 2018
We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).
Date/Time (CDT)
Monday, 4 June 2018
5:00pm Registration desk opens
5:30pm Start of meeting
7:00pm End of meeting followed by a buffet reception
Venue
Marriott Downtown Chicago
540 North Michigan Avenue
60611 Chicago
map
Agenda
Highlights in cancer immunotherapy
Alan Sandler, M.D., a.i. Global Head Oncology, Global Head Lung Cancer Franchise
Biomarkers in the era of cancer immunotherapy
Priti S. Hegde, Ph.D., Oncology Biomarker Development
Highlights late stage portfolio outside cancer immunotherapy
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development
Oncology strategy and impact on patients
Daniel O’Day, CEO Roche Pharmaceuticals
To register for the event, please follow the link (Password: Analyst2018).
A live video webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.comfollowing to the closure of the ASCO meeting.
In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link.
If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
A replay of the webcast will be available on demand on the Roche website > click here.
In addition, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to Roche, including indication of time and venue of the respective presentations at the congress. This planner can be downloaded from our website. > click here
Best regards,
Karl Mahler
Head of Investor Relations
Sabine Borngräber
Investor Relations Officer | 
